TELAVANT HOLDINGS
Summary
Telavant is developing innovative therapies to help patients living with inflammatory and fibrotic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£5,960M
Avg. Deal Size£5,960M
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
